Inflammatory Bowel Diseases · 2013 · 90 citations · 28 references
Life SciencesImmunologyOncologyInflammationInnate ImmunityMucosal ImmunologyGastrointestinal ImmunologyGut MicrobiotaInflammation-associated CarcinogenesisInnate Immune ReceptorsMucosal InflammationToll-like ReceptorsColitis-associated Colorectal CancerGut Microbiota CompositionGut Microbiota DysbiosisGut Microbiota EffectsHost-microbiome Interactions In CancerToll-like Receptor SignalingToll-like Receptor Signaling PathwaysToll-like Receptor-mediated Innate Immune Response
BACKGROUND: Microbial sensing by Toll-like receptors (TLR) and its negative regulation have an important role in the pathogenesis of inflammation-related cancer. In this study, we investigated the role of negative regulation of Toll-like receptors signaling and gut microbiota in the development of colitis-associated cancer in mouse model. METHODS: Colitis-associated cancer was induced by azoxymethane and dextran sodium sulfate in wild-type and in interleukin-1 receptor-associated kinase M (IRAK-M)-deficient mice with or without antibiotic (ATB) treatment. Local cytokine production was analyzed by multiplex cytokine assay or enzyme-linked immunosorbent assay, and regulatory T cells were analyzed by flow cytometry. Changes in microbiota composition during tumorigenesis were analyzed by pyrosequencing, and β-glucuronidase activity was measured in intestinal content by fluorescence assay. RESULTS: ATB treatment of wild-type mice reduced the incidence and severity of tumors. Compared with nontreated mice, ATB-treated mice had significantly lower numbers of regulatory T cells in colon, altered gut microbiota composition, and decreased β-glucuronidase activity. However, the β-glucuronidase activity was not as low as in germ-free mice. IRAK-M-deficient mice not only developed invasive tumors, but ATB-induced decrease in β-glucuronidase activity did not rescue them from severe carcinogenesis phenotype. Furthermore, IRAK-M-deficient mice had significantly increased levels of proinflammatory cytokines in the tumor tissue. CONCLUSIONS: We conclude that gut microbiota promotes tumorigenesis by increasing the exposure of gut epithelium to carcinogens and that IRAK-M-negative regulation is essential for colon cancer resistance even in conditions of altered microbiota. Therefore, gut microbiota and its metabolic activity could be potential targets for colitis-associated cancer therapy.
28
Harry Sokol, Bénédicte Pigneur, Laurie Watterlot et al. · Proceedings of the National Academy of Sciences · 2008 · 4.3K citations · Full text
IRAK-M Is a Negative Regulator of Toll-like Receptor Signaling
Koichi S. Kobayashi, Lorraine D. Hernandez, Jorge E. Galán et al. · Cell · 2002 · 1.3K citations · Full text
Sabine Bartosch, Alemu Fite, G.T. Macfarlane et al. · Applied and Environmental Microbiology · 2004 · 751 citations · Full text